Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

8 treatments under study, led by Locoregional 1100000 Articaine 4 Epinephrine

Research Leaders

5 sponsors active, led by Hameed Latif Hospital, Lahore

Related Conditions

Often studied with 7 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

0.0%

0 terminated out of 4 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

3Total
Not Applicable (1)
Phase 2 (1)
Phase 4 (1)

Trial Status

Completed3
Unknown1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 3 completed trials

Clinical Trials (4)

Showing 4 of 4 trials
NCT07668700Phase 2Completed

Midazolam Adjunct Therapy for Prevention of PONV in Gynecological Laparoscopy

NCT07638917Completed

BBCMADE Nomogram Validation for High-Risk Gastric Content in Sedative Endoscopy

NCT02488291Not ApplicableCompletedPrimary

Effect of Sufentanil and Ropivacaine

NCT01963754Phase 4Unknown

Compare Subperiosteal and Loco-Regional Anesthesia in Posterior Mandible Dental Implant Installation

Showing all 4 trials

Research Network

Common Treatments

  • Locoregional 1100000 Articaine 4 Epinephrine1
  • Midazolam 005 Mgkg Iv As Adjunct To Dexamethasone And Ondansetron For Ponv Prevention1
  • Subperiosteal 1100000 Articaine 4 Epinephrine1
  • Dental Implants In Posterior Mandible1
  • Bbcmade Nomogram1

Active Sponsors

  • Hameed Latif Hospital, Lahore1
  • Implantology Institute1
  • Fusun Gozen1
  • Fudan University1
  • Shanghai Jiao Tong University School of Medicine1

Top Investigators

Related Conditions

  • Gynecological Laparoscopic Surgery1
  • Gastric Content Aspiration Risk1
  • Dental Implant Failed1
  • Anesthesia Morbidity1
  • Postoperative Nausea And Vomiting Ponv1

Activity Timeline